Abstract
Loss of function mutations in granulin (GRN) are linked to two distinct neurological disorders, frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL). It is so far unknown how a complete loss of GRN in NCL and partial loss of GRN in FTLD can result in such distinct diseases. In zebrafish, there are two GRN homologues, Granulin A (Grna) and Granulin B (Grnb). We have generated stable Grna and Grnb loss of function zebrafish mutants by zinc finger nuclease mediated genome editing. Surprisingly, the grna and grnb single and double mutants display neither spinal motor neuron axonopathies nor a reduced number of myogenic progenitor cells as previously reported for Grna and Grnb knock down embryos. Additionally, grna-/-;grnb-/- double mutants have no obvious FTLD- and NCL-related biochemical and neuropathological phenotypes. Taken together, the Grna and Grnb single and double knock out zebrafish lack any obvious morphological, pathological and biochemical phenotypes. Loss of zebrafish Grna and Grnb might therefore either be fully compensated or only become symptomatic upon additional challenge.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Base Sequence
-
Female
-
Frontotemporal Lobar Degeneration / genetics*
-
Gene Knockout Techniques*
-
Humans
-
Intercellular Signaling Peptides and Proteins / deficiency*
-
Intercellular Signaling Peptides and Proteins / genetics*
-
Male
-
Molecular Sequence Data
-
Motor Neurons / cytology
-
Mutation
-
Neuronal Ceroid-Lipofuscinoses / genetics*
-
Phenotype
-
Progranulins
-
Spinal Cord / cytology
-
Zebrafish Proteins / deficiency
-
Zebrafish Proteins / genetics
-
Zebrafish*
Substances
-
Intercellular Signaling Peptides and Proteins
-
Progranulins
-
Zebrafish Proteins
Grants and funding
This work was supported by the Sonderforschungsbereich 596, International Max Planck Research School for Molecular and Cellular Life Sciences (B. So.), the Elite Network of Bavaria (B. So.), a Short Term Scientific Mission COST Action BM0804 (B.So.), the Batten Disease Family Association (C.R.), the European Research Council under the European Union’s Seventh Framework Program FP7/2007–2013)/ ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.), the general legacy of Mrs. Ammer (to the Ludwig-Maximilians University/ C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.